Development of a de novo tumorous necrotic lesion in the liver after transcatheter arterial embolization combined with iodized oil infusion: Report of a case

Hirota, Masahiko; Arakawa, Masahiro; Shigaki, Nobuyuki; Ohshima, Hisami; Koga, Yukinori; Kawakami, Takao; Yamasaki, Katsumi

doi:10.1007/bf00311992

Cited by 3 publications

(2 citation statements)

References 8 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…[1][2][3][4] This treatment can be applied to hepatocellular carcinoma (HCC) with multicentric carcinogenesis or intrahepatic metastasis, unresectable multiple metastases, and other lesions with impaired liver function. Compared with other minimally invasive treatments such as percutaneous ethanol injection therapy [5][6][7] or chemoembolization, [8][9][10][11][12] MCT has been evaluated to offer potentially complete tumor ablation. Initially, the indication had been for tumors less than 3 cm in diameter; 1 however, it has now extended to include HCCs larger than 5 cm in diameter.…”

Section: Introductionmentioning

confidence: 99%

Complications and Management of Microwave Coagulation Therapy for Primary and Metastatic Liver Tumors

et al. 1998

Self Cite

View full text Add to dashboard Cite

Microwave coagulation therapy (MCT) has been widely used, both percutaneously and directly, as effective minimal invasive therapy for liver tumors. To facilitate the use of MCT, we describe the complications we have encountered, and their possible management and prophylaxis. MCT was performed for 42 patients with hepatocellular carcinoma (HCC) and for 29 with metastatic liver tumors, following which complications developed in 14.2% and 20.6% of the HCC and metastatic groups, respectively. The complications included abscess, biloma, bleeding, hepatic failure, and dissemination of cancer cells. In the HCC group, the mean value of tumor size and the clinical stage of patients with complications were significantly larger (P = 0.006) and higher (P = 0.032), respectively, than those of patients without complications. The incidence of complications increased significantly when the tumor size was more than 4cm (P = 0.008). Abscesses and bleeding were successfully treated using percutaneous drainage and interventional angiography, respectively, but as the other serious complications were not able to be treated effectively once induced, prophylaxis is important to facilitate MCT. Transcatheter cooling of the intrahepatic bile duct during MCT and the administration of an anticancer agent into the abdominal cavity are recommended to prevent biloma and dissemination, respectively. MCT is indicated for tumors less than 4 cm in diameter to reduce the risk of complications. The prophylaxis and treatment of these complications enhance the safety of MCT.

show abstract

Section: Introductionmentioning

confidence: 99%

Complications and Management of Microwave Coagulation Therapy for Primary and Metastatic Liver Tumors

et al. 1998

Self Cite

View full text Add to dashboard Cite

show abstract

“…[12][13][14][15] Seki et al 8 reported two cases of hepatic infarction after PEIT for HCC. In both patients, TAI with SMANCS/Lipiodol had been performed previously.…”

Section: Discussionmentioning

confidence: 98%

Multiple hepatic infarction after transcatheter arterial infusion with SMANCS

Abe

Yamasaki

Nakano

et al. 2001

Journal of Gastroenterology

View full text Add to dashboard Cite

We report a patient with hepatocellular carcinoma who developed multiple hepatic infarction after transcatheter arterial infusion (TAI) with a suspension of styrene maleic acid neocarzinostatin (SMANCS) and Lipiodol (SMANCS/Lipiodol). The parameters of hepatic functional reserve were apparently decreased after the second TAI with SMANCS/Lipiodol, and the patient died of hepatic failure 103 days after the second TAI. The autopsy liver specimen revealed multiple hepatic infarctions associated with peripheral arterial stenosis or occlusion, and portal thrombosis. It is speculated that both the arterial occlusion and the portal thrombosis caused the hepatic infarction, based on a long-term insufficiency of blood supply to the hepatocytes arising from toxic arteritis caused by SMANCS/Lipiodol.

show abstract

Infusion of 50 % glucose solution to occlude an intrahepatic portosystemic venous shunt before percutaneous transhepatic portal embolization: report of a case

et al. 2013

View full text Add to dashboard Cite

A 68-year-old man with cholangiocarcinoma underwent percutaneous transhepatic portal embolization to expand the indication for hepatic resection. Selective right posterior portography revealed an intrahepatic portosystemic venous shunt (IPSVS) connecting the segment VII branch to the right hepatic venous branch. An infusion of 50 % glucose solution was given to occlude the shunt. This is novel management for IPSVSs when they are numerous, small, or torturous, and makes the subsequent procedures simpler, shorter, and less expensive.

show abstract

Development of a de novo tumorous necrotic lesion in the liver after transcatheter arterial embolization combined with iodized oil infusion: Report of a case

Cited by 3 publications

References 8 publications

Complications and Management of Microwave Coagulation Therapy for Primary and Metastatic Liver Tumors

Complications and Management of Microwave Coagulation Therapy for Primary and Metastatic Liver Tumors

Multiple hepatic infarction after transcatheter arterial infusion with SMANCS

Infusion of 50 % glucose solution to occlude an intrahepatic portosystemic venous shunt before percutaneous transhepatic portal embolization: report of a case

Contact Info

Product

Resources

About